EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Non-Dilated Left Ventricular Cardiomyopathy vs. Dilated Cardiomyopathy: Clinical Background and Outcomes

Yuko Eda, Takeru Nabeta iD, Saeko Iikura, Yu Takigami, Teppei Fujita, Yuichiro Iida, Yuki Ikeda, Shunsuke Ishii, Junya Ako

ESC Heart Failure · 2024

DOI: 10.1002/ehf2.14711 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift ESC Heart Failure, 2024. Verfasst von Yuko Eda und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan. Hauptthemen laut MEDLINE: Cardiomyopathy, Dilated, Stroke Volume, Ventricular Function, Left. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Non-dilated left ventricular cardiomyopathy (NDLVC) was proposed as a new category of cardiomyopathy that included patients with non-left ventricular (LV) dilatation, LV wall motion abnormality, or LV scar. However, the clinical background and event rates of NDLVC were unclear. The aim of this study was to examine the characteristics and event rates of patients with NDLVC and reduced LV ejection fraction (NDLVC–REF) in comparison with those with dilated cardiomyopathy (DCM). Methods and results We retrospectively included 363 patients with newly diagnosed non-ischaemic cardiomyopathy and reduced LV ejection fraction (<50%) between December 2004 and January 2018. Patients who did not have LV dilatation (LV dimension index of ≦31 mm/m2 in men and ≦34 mm/m2 in women) were categorized as NDLVC–REF (n = 80, 22.2%), and the remaining patients were categorized as DCM. Cardiac events were defined as sudden cardiac death and rehospitalization for heart failure. Patients with NDLVC–REF had a higher prevalence of atrial fibrillation and a higher LV ejection fraction than those with DCM at baseline. LV ejection fraction was higher and LV end-diastolic diameter was smaller in patients with NDLVC–REF than in those with DCM at all time points after diagnosis. During the median follow-up period of 68.8 months (interquartile range: 33.0–93.7 months), 44 patients experienced cardiac events. The Kaplan–Meier curves showed no significant differences in the probability of cardiac events among NDLVC–REF and DCM patients (P = 0.349). However, patients with NDLVC–REF and LV dilatation after diagnosis (14%) had a higher risk of cardiac events than those with NDLVC–REF without LV dilatation (P = 0.049).

Conclusions

There was no significant difference in the incidence of cardiac events between NDLVC–REF and DCM. Among NDLVC–REF patients, 18% of patients who showed LV dilatation after diagnosis had poor outcomes. Therefore, both NDLVC–REF and DCM patients may require equivalent attention to follow-up and regular assessment of LV function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, DilatedStroke VolumeVentricular Function, LeftHumansMaleFemaleRetrospective StudiesMiddle AgedFollow-Up StudiesEchocardiographyPrognosisHeart VentriclesAgedSurvival RateDeath, Sudden, Cardiac

Stichwörter der Autor:innen

CardiomyopathyHeart failureLeft ventricular functionPrognosis

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0374, Japan.
  • Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.

ORCID-Profile: Takeru Nabeta

Zitieren

APA

Eda, Y., Nabeta, T., Iikura, S., Takigami, Y., Fujita, T., Iida, Y., Ikeda, Y., Ishii, S., & Ako, J. (2024). Non-Dilated Left Ventricular Cardiomyopathy vs. Dilated Cardiomyopathy: Clinical Background and Outcomes. ESC Heart Failure. https://doi.org/10.1002/ehf2.14711

Vancouver

Eda Y, Nabeta T, Iikura S, Takigami Y, Fujita T, Iida Y, et al. Non-Dilated Left Ventricular Cardiomyopathy vs. Dilated Cardiomyopathy: Clinical Background and Outcomes. ESC Heart Failure. 2024. doi:10.1002/ehf2.14711

BibTeX
@article{Eda2024,
  author = {Eda, Yuko and Nabeta, Takeru and Iikura, Saeko and Takigami, Yu and Fujita, Teppei and Iida, Yuichiro and Ikeda, Yuki and Ishii, Shunsuke and Ako, Junya},
  title = {Non-Dilated Left Ventricular Cardiomyopathy vs. Dilated Cardiomyopathy: Clinical Background and Outcomes},
  journal = {ESC Heart Failure},
  year = {2024},
  doi = {10.1002/ehf2.14711}
}
Kostenlos starten →